Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Effect of botulinum toxin type A on hyperalgesia alloxan and streptozotocin induced diabetic neuropathy (CROSBI ID 525009)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Lacković, Zdravko ; Bach-Rojecky, Lidija ; Šalkovic-Petrišić, Melita Effect of botulinum toxin type A on hyperalgesia alloxan and streptozotocin induced diabetic neuropathy // Acta pharmacologica Sinica / Vanhoute, Paul M. (ur.). 2006. str. 312-312

Podaci o odgovornosti

Lacković, Zdravko ; Bach-Rojecky, Lidija ; Šalkovic-Petrišić, Melita

engleski

Effect of botulinum toxin type A on hyperalgesia alloxan and streptozotocin induced diabetic neuropathy

Recently we found that botulinum toxin type A (BTX-A) reduced pain hypersensitivity in rats with surgical neuropathy (Bach-Rojecky at al. J. Neural Transm 2005 ; 112:215). Here we report that BTX-A has antinociceptive activity in diabetic neuropathy, too. Adult male Wistar rats were made diabetic by subcutaneous injection of alloxan or streptozotocin. After 5 days only animals with a tail-vein blood-glucose concentration of above 15 mmol/l were considered diabetic and included in the study. Paw-pressure and hot plate tests were first performed 3 weeks following betacitotoxic injection. Only the animals with significantly different mechanical thresholds compared to control group were considered neuropathic (hyperalgesic) and were than subjected to BTX-A treatment. On day 5 after BTX-A 5 and 7 U/kg treatment significant antinociceptive effect was observed i.e. diminished number of flinches and shakes of the formalin-injected paw. The lowest used dose (3 U/kg) was ineffective. With the paw pressure test results were practically the same. To our knowledge this is the first demonstration that a single peripheral injection of BTX might have antinociceptive effect in diabetic neuropathy.

botulinum toxin type A; neuropathic pain; antinociception; diabetes mellitus

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

312-312.

2006.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Acta pharmacologica Sinica

Vanhoute, Paul M.

Peking: Chinese Pharmacological Society

1671-4083

Podaci o skupu

World Congress of Pharmacology (15 ; 2006)

poster

02.07.2006-07.07.2006

Peking, Kina

Povezanost rada

Temeljne medicinske znanosti

Poveznice
Indeksiranost